Share this article on:

Pandemic Influenza A H1N1 Vaccination and Subsequent Risk of Type 1 Diabetes in Norway

Ruiz, Paz L. D.; Stene, Lars C.; Gulseth, Hanne L.; Tapia, German; Trogstad, Lill; Bakken, Inger J.; Håberg, Siri E.

doi: 10.1097/EDE.0000000000000748
Letters

Supplemental Digital Content is available in the text.

Norwegian Institute of Public Health, Oslo, Norway, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

Norwegian Institute of Public Health, Oslo, Norway

Norwegian Institute of Public Health, Oslo, Norway, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway

Norwegian Institute of Public Health, Oslo, Norway

All authors have completed and submitted the ICMJE form for Disclosure of Potential Conflicts of Interest. No disclosures were reported.

This research was partly supported by the Norwegian Institute of Public Health and a grant from the Norwegian Health South East Authority.

Data sharing: No additional data included. Data used in this study are available from the included registers with approval from the Regional Committee for Medical and Health Research Ethics and the Norwegian Data Protection Authority. Code for replication can be requested.

Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.